Medicinal correction with angiogenesis inhibitors of hemodynamic disorders in choroid in patients with the exudative form of age-related macular degeneration
DOI:
https://doi.org/10.31288/oftalmolzh201325155Keywords:
age-related macular degeneration, rheophhtalmography, medicamentous treatmentAbstract
Antiischemic medicamentous treatment of wet AMD and hemodynamic disturbances in choroid is advisable to supplement the primary of anti-VEGF therapy. It allows for 3 months ahead recovering blood circulation in the eye.
References
1.Король А. Р. Гемодинамика глаза и нарушение кро-воснабжения в сосудистой оболочке глаза у больных экссудативной формой возрастной дегенерации макулы / А. Р. Король, Н. И. Храменко, Т. Б. Кустрин // Офтальмол. журн. - 2012. - № 6. - С. 43- 46.
2.Король А. Р. Классификация экссудативной формы возрастной макулярной дегенерации по степени тяжести / А. Р. Король, Е. И. Драгомирецкая, Т. Б. Кустрин // Сучасні медичні технології. - 2012 (в печати).
3.Пасечникова Н. В. Клиническая классификация и тактика лазерного лечения больных с диабетическим макулярным отеком / Н. В. Пасечникова, В. А. Науменко, А. В. Зборовская, А. Р. Король // Матеріали II міжнародної наук. - практ. конф. «Актуальні проблеми діагностики та лікування судинно-ендокринних захворювань органа зору». - Київ. - 2005. - С.89- 90.
4.Пасечникова Н. В. Клиническая классификация и тактика лазерного лечения больных с диабетическим макулярным отеком / Н. В. Пасечникова, В. А. Нау-менко, А. В. Зборовская // Одеський медичний жур¬нал. - № 6(116). - 2009. - С.77-79
5.Dimitrova G. Colour Doppler Imaging of Ocular and Or¬bital Blood Vessels in Retinal Diseases / G. Dimitrova // European Ophthalmic Review. - 2011. - Vol. 5(1). - P. 16-19. 15. https://doi.org/10.17925/EOR.2011.05.01.16
6.Toklu Y. Short-term effects of intravitreal bevacizumab (Avastin(®)) on retrobulbar hemodynamics in patients with neovascular age-related macular degeneration / Y Toklu, H. B. Cakmak, S. Raza [et al] // Acta Ophthal¬mol. - 2011. - Vol.89. - Issue 1. - P. 41-45.https://doi.org/10.1111/j.1755-3768.2010.02075.x
7.Yamazaki T. Subfoveal choroidal thickness after ranibi-zumab therapy for neovascular age-related macular de-generation: 12-month results / T. Yamazaki, H. Koizumi, T. Yamagishi [et al] // Ophthalmology. - 2012. - Vol. 119(8) - P.1621- 1627.https://doi.org/10.1016/j.ophtha.2012.02.022
Downloads
Published
Issue
Section
License
Copyright (c) 2013 А. Р. Король, Н. И. Храменко, О. С. Задорожный, Т. Б. Кустрин
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) that allows users to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author as long as they cite the source.
COPYRIGHT NOTICE
Authors who publish in this journal agree to the following terms:
- Authors hold copyright immediately after publication of their works and retain publishing rights without any restrictions.
- The copyright commencement date complies the publication date of the issue, where the article is included in.
DEPOSIT POLICY
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) during the editorial process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work with an acknowledgement of its initial publication in this journal.
- Post-print (post-refereeing manuscript version) and publisher's PDF-version self-archiving is allowed.
- Archiving the pre-print (pre-refereeing manuscript version) not allowed.
